Global CRO inVentiv Health has created two new positions to lead its business in Europe and Asia.

Dan Feldman, who established and led inVentiv’s operation in Japan, will take on the new position of president of inVentiv Health Europe. The position will oversee the growth of business across all inVentiv Health segments—clinical research, commercialization and consulting—and will lead development of inVentiv’s approach to convergent services. 

Stephen J. Walter will join the company as executive vice president for Asia. Walter formerly was managing director for Merck Sharpe & Dhome in Vietnam and Cambodia. Previously, he worked as general manager and vice president of consulting and services for IMS Health, based in Singapore. For Bristol-Myers Squibb, he helped launch Entecavir in the Asia Pacific region and was then regional director of business development.

Walter will oversee growth and management of all inVentiv Health business throughout the region, including the expansion of inVentiv’s clinical research capabilities in China. 

Walter, who will be based in Shanghai, will oversee inVentiv operations in the ASEAN nations, Australia and New Zealand, in addition to China and Korea.  He also will assume responsibility for Japan at the end of this year, when he takes the reins from Feldman.